Genspect Contributes to HSE Ireland’s Gender Healthcare Evidence Review

By Genspect

Genspect has submitted peer-reviewed research to HSE Ireland’s consultation on their updated Model of Care for gender healthcare services.

What HSE Is Doing

HSE is reviewing evidence to answer two questions:

  1. What clinical needs exist in populations attending gender services?
  2. What are the clinical outcomes of medical interventions like hormone therapy?

They’ve reviewed 2,000+ papers and included 168 studies so far. Now they want public input to ensure nothing important is missed.

Submit evidence here: https://hli.ie/gender_health
Deadline: 31 August 2025

What We’ve Submitted

We’ve sent peer-reviewed research focusing on clinical outcomes—the second question that often gets less attention but matters enormously.

Our submissions cover:

  • Long-term health impacts after medical interventions
  • Mental health trajectories across different treatment paths
  • Detransition experiences from international cohorts
  • Autism/ADHD co-occurrence in gender-referred populations
  • Cardiovascular, bone health, and fertility outcomes
  • Surgical outcomes and revision rates

Why This Matters

Understanding who seeks services is important. But knowing what happens to them afterwards? That’s essential.

HSE’s review of clinical needs provides valuable context. Our outcomes research adds another crucial piece—what actually happens when people take different paths through gender-related distress.

Get Involved

→ Have relevant research?
Submit peer-reviewed studies before 31 August at https://hli.ie/gender_health

→ Want to explore the evidence?
Stats for Gender (statsforgender.org), our searchable database, catalogues peer-reviewed studies across the field.

Next Steps

We hope this consultation leads to a Model of Care based on comprehensive evidence—one that examines all pathways and outcomes, not just predetermined conclusions.

Genspect is here to support this process. We’re ready to share our expertise and work with HSE and other stakeholders as this develops.